A genomic platform for surveillance and antigen discovery in Plasmodium spp. using long-read amplicon sequencing

Cell Rep Methods. 2023 Sep 25;3(9):100574. doi: 10.1016/j.crmeth.2023.100574. Epub 2023 Aug 29.

Abstract

Many vaccine candidate proteins in the malaria parasite Plasmodium falciparum are under strong immunological pressure and confer antigenic diversity. We present a sequencing and data analysis platform for the genomic surveillance of the insertion or deletion (indel)-rich antigens merozoite surface protein 1 (MSP1), MSP2, glutamate-rich protein (GLURP), and CSP from P. falciparum using long-read circular consensus sequencing (CCS) in multiclonal malaria isolates. Our platform uses 40 PCR primers per gene to asymmetrically barcode and identify multiclonal infections in pools of up to 384 samples. With msp2, we validated the method using 235 mock infections combining 10 synthetic variants at different concentrations and infection complexities. We applied this strategy to P. falciparum isolates from a longitudinal cohort in Tanzania. Finally, we constructed an analysis pipeline that streamlines the processing and interpretation of epidemiological and antigenic diversity data from demultiplexed FASTQ files. This platform can be easily adapted to other polymorphic antigens of interest in Plasmodium or any other human pathogen.

Keywords: CP: Biotechnology; CP: Microbiology; antigen discovery; circumsporozoite protein; genomic surveillance; glutamate-rich protein; long-read sequencing; malaria epidemiology; merozoite surface protein 1; merozoite surface protein 2.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Genomics
  • Glutamic Acid
  • Humans
  • Malaria, Falciparum* / epidemiology
  • Plasmodium falciparum / genetics
  • Plasmodium*

Substances

  • Glutamic Acid